Progression of steroid-associated osteoporosis after heart transplantation Jochen Cremer, MD, Martin Strüber, MD, Ingrid Wagenbreth, MD, Johannes Nischelsky, MD, Stefanos Demertzis, MD, Thomas Graeter, MD, Conny Abraham, PhD, Axel Haverich, MD The Annals of Thoracic Surgery Volume 67, Issue 1, Pages 130-133 (January 1999) DOI: 10.1016/S0003-4975(98)01040-6
Fig 1 Maintenance steroid dose (prednisone) after 1, 3, 6, 9, and 12 months in each group. The Annals of Thoracic Surgery 1999 67, 130-133DOI: (10.1016/S0003-4975(98)01040-6)
Fig 2 Course of trabecular bone density (mean of T12, L1, L2, and L3) in the elcitonin and placebo groups. (∗p < 0.05.) The Annals of Thoracic Surgery 1999 67, 130-133DOI: (10.1016/S0003-4975(98)01040-6)
Fig 3 Course of cortical bone density (mean of T12, L1, L2, and L3) in the elcitonin and placebo groups. (∗p < 0.05.) The Annals of Thoracic Surgery 1999 67, 130-133DOI: (10.1016/S0003-4975(98)01040-6)
Fig 4 Course of trabecular bone density (mean of T12, L1, L2, and L3) in men older or younger than 40 years independent of elcitonin treatment. (∗p < 0.05.) The Annals of Thoracic Surgery 1999 67, 130-133DOI: (10.1016/S0003-4975(98)01040-6)